Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

SHE:002728 Revenue

Teyi Pharmaceutical Group Co.,Ltd had revenue of 209.87M CNY in the quarter ending March 31, 2026, a decrease of -28.89%. This brings the company's revenue in the last twelve months to 839.27M, up 2.56% year-over-year. In the year 2025, Teyi Pharmaceutical Group Co.,Ltd had annual revenue of 924.53M with 34.42% growth.

• Revenue (ttm): 839.27M
• Revenue Growth: +2.56%
• P/S Ratio: 5.65
• Revenue / Employee: 585.26K
• Employees: 1,434
• Market Cap: 4.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	924.53M	236.74M	34.42%
Dec 31, 2024	687.79M	-379.43M	-35.55%
Dec 31, 2023	1.07B	180.64M	20.38%
Dec 31, 2022	886.57M	128.41M	16.94%
Jan 1, 2022	758.16M	125.47M	19.83%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error